FDI World Dental Federation launches toolkit on how to make dentistry more sustainable
plus
Actualités sur Santè / Médecine
European Society for Medical Oncology (ESMO)
ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability
Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...
plusAlmirall: Lebrikizumab Dosed Every Four Weeks Maintained Durable Skin Clearance in Phase 3 Monotherapy Atopic Dermatitis Trials
Barcelona, Spain (ots/PRNewswire) - - New, late-breaking data show lebrikizumab responders reported long-lasting results at one year of treatment across measures of improvement in skin clearance, itch and disease extent and severity - Results suggest less frequent, every four week dosing of lebrikizumab provided ...
plusSIGMA-ALDRICH AND GENOWAY EXPAND THEIR CRISPR/CAS9 STRATEGIC ALLIANCE
ST. Louis, Mo. and Lyon, France (ots/PRNewswire) - Sigma-Aldrich Co LLC (a subsidiary of Merck KGaA, Darmstadt, Germany), a leading science and technology company and provider of genome editing research tools, and genOway the leading company in the preclinical research model space, today announced a new structure to their 2018 strategic alliance in the CRISPR/Cas9 ...
plusONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS
Lausanne, Switzerland (ots) - - International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics - The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly ...
plusHovione expands drug product offering with a new manufacturing line dedicated to Continuous Tableting
Lisbon, Portugal (ots/PRNewswire) - Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal. In addition, to ...
plusHospitainer: Coalition of Dutch companies provides mobile hospitals and rebuilds Ukrainian healthcare
Vaassen, Netherlands (ots/PRNewswire) - Since the beginning of the war in Ukraine 6 months ago there have been more than 600 attacks on hospitals and clinics. 450 hospitals and clinics have been damaged or destroyed[1] and as a result, access to critical health care for the injured and chronically ill has been ...
plusZerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Lisbon, Portugal (ots/PRNewswire) - Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/dietary supplements field. Many dietary supplements suffer from low solubility. This results in poor bioavailability and ...
plusMedison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel
Petach Tikvah, Israel (ots/PRNewswire) - Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today the expansion of its partnership with Albireo to a multi-regional agreement to commercialize Odevixibat in ...
plusCatalytic Investment to Improve Community Health Care for Millions Across Africa
Geneva (ots/PRNewswire) - The Global Fund collaborates with the Johnson & Johnson Foundation and the Skoll Foundation to Launch the Africa Frontline First Catalytic Fund - Private sector investments to the Global Fund's Africa Frontline First Catalytic Fund from the Johnson & Johnson Foundation and the Skoll Foundation totaling US$ 25 million. - The Global Fund to ...
plusRafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases
Jerusalem and Prague, Czech Republic (ots/PRNewswire) - Rafa Laboratories LTD. ("Rafa") and ExCEEd Orphan s.r.o ("ExCEEd") announced today a strategic collaboration for medicines addressing rare diseases in Central and Eastern Europe ("CEE") and Israel. Under the agreement, and as part of its strategy to become an ...
plusGlobal Fund Reports Significant Progress in Breaking Down Human Rights-Related Barriers to HIV and TB Services
Montreal (ots/PRNewswire) - A new report released by the Global Fund today at the 24th International AIDS Conference unveils key findings of the activities supported by the Global Fund's Breaking Down Barriers initiative, a groundbreaking program launched in 2017 to provide intensive financial and technical support ...
plusMenarini Silicon Biosystems; DIESSE
Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America
Chicago (ots/PRNewswire) - The commercial agreement to promote and sell CHORUS TRIO immunometric assay solutions in the U.S. Market was announced jointly by the two companies during the AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago. Menarini Silicon Biosystems Inc, a US company part of the Menarini ...
plusABCAM PLC First Half Trading Update
Cambridge, England (ots/PRNewswire) - Abcam plc ("Abcam", "Company", "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following trading update for the six-month period ending 30 June 2022. The Company will release its full results for the six-month period on 12 September 2022. The Group expects to report total revenues for the six-month period of ...
plusMedimap Announces New Chief Executive Officer
Vancouver, Bc (ots/PRNewswire) - CEO Thomas Jankowski intends to expand company's global reach Medimap has officially named Thomas Jankowski as the company's new chief executive officer replacing Blake Adam, the company's founder and former CEO, who has joined Medimap's board of directors. Mr. Jankowski is an innovative digital marketing executive with extensive management and hands-on experience in technology, fintech ...
plusInfosys to Acquire Life Sciences Consulting and Technology Leader, BASE life science
Bengaluru, India and Copenhagen, Denmark (ots/PRNewswire) - Acquisition to deepen life sciences domain capabilities and strengthen footprint across Europe Infosys (NSE, BSE, NYSE: INFY) a global leader in next-generation digital services and consulting, today announced a definitive agreement to acquire BASE life science, a leading technology and consulting firm in the ...
plusBiotech Food Colorant Startup Phytolon Closes $14.5 Million Series A Funding Round, Led by DSM Venturing
Yokneam Illit, Israel (ots/PRNewswire) - Phytolon, a developer of fermentation-based natural food colors, announced today it has secured $14.5 million in funding, led by DSM Venturing, to further progress its technology towards commercialization, with participation from Cibus Fund, Ginkgo Bioworks (in-kind ...
plusNeuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms
Dublin (ots/PRNewswire) - - Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire® - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment - 87.8% said they would recommend ...
plusDSM-Firmenich update on public exchange offer process
Heerlen, Netherlands and Geneva (ots/PRNewswire) - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. NOT FOR GENERAL RELEASE IN THE UNITED STATES – SEE FURTHER INFORMATION BELOW. This announcement is not for release, publication or distribution, ...
plusAbcam: Appointment of Vice President of Investor Relations
Cambridge, England (ots/PRNewswire) - Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations. Tommy, who will be based in our Waltham, MA office, has over 20 years' experience in the life sciences sector, largely focused in the area of research tools. He joins ...
plusPoda Lifestyle and Wellness Ltd.
PODA Completes Multiparty Sale of Intellectual Property Assets for US$100.5 Million
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("PODA" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce that, further to its news release dated May 13, 2022, the Company, together with Ryan Selby and Ryan Karkairan (the "Owners"), has completed the sale of substantially all of the assets and properties used in the Company's ...
plusDSM and Firmenich confirm leadership team for proposed combined company DSM-Firmenich
Geneva and Heerlen, Netherlands (ots/PRNewswire) - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. NOT FOR GENERAL RELEASE IN THE UNITED STATES – SEE FURTHER INFORMATION BELOW. DSM and ...
plusProfessor Lars Iversen joins MC2 Therapeutics as new Chief Medical Officer
Copenhagen (ots/PRNewswire) - MC2 Therapeutics A/S, a commercial stage pharmaceutical company, has named Lars Iversen, MD, DMSc an esteemed chair professor in dermatology at Aarhus University Hospital and at Aarhus University, its new full-time Chief Medical Officer (CMO) as of October 1st, 2022. Professor Lars Iversen will be a key member of the Executive Team at MC2 ...
plusMedison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma
Petach Tikvah, Israel (ots/PRNewswire) - KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly ...
plusMedison Pharma Announces Multi-Regional Partnership Agreement with argenx to Commercialize Efgartigimod Across Europe and Israel
Petach Tikvah, Israel (ots/PRNewswire) - Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today an exclusive multi-regional agreement with argenx to commercialize efgartigimod in 14 countries, including ...
plusPODA Announces Filing of Information Circular for Special Meeting
VANCOUVER, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("PODA" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce that, further to its news release dated May 13, 2022 in respect of the proposed sale of all or substantially all of the Company's assets to Altria Client Services LLC ("ALCS"), a subsidiary of Altria Group, Inc. (NYSE: MO), it ...
plusTau-targeting Alzheimer's treatment, HMTM, moving toward regulatory submission based on initial data from TauRx's LUCIDITY trial
Singapore (ots/PRNewswire) - - LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (HMTM) decline at a rate substantially less than is typical in Alzheimer's based on published research - Safety profile is favourable and consistent with previous HMTM studies - TauRx will now pursue ...
plusFilterlex Medical Announces Positive Results from A First-In-Human Study for the CAPTIS® Full-Body Embolic Protection Device
Caesarea, Israel (ots/PRNewswire) - Cardiovascular data presented at EuroPCR 2022 demonstrates successful device performance during a TAVR procedure with no complications. Filterlex Medical Ltd., a cardiovascular medical device startup, announced today results from a first-in-human (FIH) study demonstrating the ...
plusOxitec and the Government of Djibouti Announce New Multi-Year Partnership to Fight Invasive Malaria-Transmitting Mosquitoes Threatening the Horn of Africa
Oxford, England (ots/PRNewswire) - - With strong support from the Government of Djibouti, this program will pilot a new Friendly™ mosquito control technology to combat the growing threat to the region posed by the rapidly spreading malaria vector, Anopheles stephensi. - Oxitec will work hand-in-hand with the ...
plusFIRMENICH ANNOUNCES SOLID RESULTS OUTLOOK FOR FISCAL YEAR ENDED 30 JUNE 2022
Geneva (ots/PRNewswire) - This announcement is not for release, publication or distribution, directly or indirectly (in whole or in part) in, into, or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction, including the United States, Canada, South Africa, Australia and Japan. In conjunction with ...
plus
Précédent234567891011Suivant